中智全球(06819.HK)中期由盈轉虧140萬美元
格隆匯2月26日丨中智全球(06819.HK)發佈公吿,截至2020年12月31日止6個月,公司總收益1900萬美元,同比略微增長;期間淨虧損140萬美元,上年同期溢利240萬美元;每股虧損0.003美元。
於2020年12月31日,公司有10,747間註冊醫療場所,較2020年6月30日減少4.3%。截至2020年12月31日,公司共有114,109名支援醫療行業的會員,較2020年6月30日減少6.0%。該減少主要歸因於COVID-19疫情令醫療場所非危急病人醫療程序暫時被延誤。由於醫療場所重新營業,可進行該等重大醫療程序,故公司相信,相關醫療專業人士將會續訂。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.